118 related articles for article (PubMed ID: 35507797)
1. Recombinant Human Lactoferrin Augments Epirubicin Chemotherapy in Solid Ehrlich Carcinoma Bearing Mice.
El-Ashmawy NE; Khedr EG; El-Kady AY; Al-Ashmawy GM
Curr Drug Saf; 2023; 18(3):345-354. PubMed ID: 35507797
[TBL] [Abstract][Full Text] [Related]
2. Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy.
Varadhachary A; Wolf JS; Petrak K; O'Malley BW; Spadaro M; Curcio C; Forni G; Pericle F
Int J Cancer; 2004 Sep; 111(3):398-403. PubMed ID: 15221967
[TBL] [Abstract][Full Text] [Related]
3. CHO expressed recombinant human lactoferrin as an adjuvant for BCG.
Hwang SA; Kruzel ML; Actor JK
Int J Immunopathol Pharmacol; 2015 Dec; 28(4):452-68. PubMed ID: 26315722
[TBL] [Abstract][Full Text] [Related]
4. The effect of recombinant human lactoferrin from the milk of transgenic cows on Salmonella enterica serovar typhimurium infection in mice.
Wu J; Hu Y; Du C; Piao J; Yang L; Yang X
Food Funct; 2016 Jan; 7(1):308-14. PubMed ID: 26469086
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human lactoferrin induces apoptosis, disruption of F-actin structure and cell cycle arrest with selective cytotoxicity on human triple negative breast cancer cells.
Iglesias-Figueroa BF; Siqueiros-Cendón TS; Gutierrez DA; Aguilera RJ; Espinoza-Sánchez EA; Arévalo-Gallegos S; Varela-Ramirez A; Rascón-Cruz Q
Apoptosis; 2019 Aug; 24(7-8):562-577. PubMed ID: 30941553
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin.
Zakharova ET; Sokolov AV; Pavlichenko NN; Kostevich VA; Abdurasulova IN; Chechushkov AV; Voynova IV; Elizarova AY; Kolmakov NN; Bass MG; Semak IV; Budevich AI; Kozhin PM; Zenkov NK; Klimenko VM; Kirik OV; Korzhevskii DE; Menshchikova EB; Vasilyev VB
Biometals; 2018 Jun; 31(3):425-443. PubMed ID: 29748743
[TBL] [Abstract][Full Text] [Related]
7. Novel recombinant human lactoferrin: differential activation of oxidative stress related gene expression.
Kruzel ML; Actor JK; Zimecki M; Wise J; Płoszaj P; Mirza S; Kruzel M; Hwang SA; Ba X; Boldogh I
J Biotechnol; 2013 Dec; 168(4):666-75. PubMed ID: 24070904
[TBL] [Abstract][Full Text] [Related]
8. Lactoferrin, a Critical Player in Neonate Intestinal Development: RHLF may be a Good Choice in Formula.
Wang W; Cheng Z; Wang X; An Q; Huang K; Dai Y; Meng Q; Zhang Y
J Agric Food Chem; 2021 Aug; 69(31):8726-8736. PubMed ID: 34323077
[TBL] [Abstract][Full Text] [Related]
9. A Novel Human Recombinant Lactoferrin Inhibits Lung Adenocarcinoma Cell Growth and Migration with No Cytotoxic Effect on Normal Human Epithelial Cells.
Olszewska P; Pazdrak B; Kruzel ML
Arch Immunol Ther Exp (Warsz); 2021 Nov; 69(1):33. PubMed ID: 34748082
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori.
Yuan Y; Wu Q; Cheng G; Liu X; Liu S; Luo J; Zhang A; Bian L; Chen J; Lv J; Dong X; Yang G; Zhu Y; Ma L
Int J Mol Med; 2015 Aug; 36(2):363-8. PubMed ID: 26080893
[TBL] [Abstract][Full Text] [Related]
11. Effects of Recombinant Human Lactoferrin on Osteoblast Growth and Bone Status in Piglets.
Li Q; Zhao J; Hu W; Wang J; Yu T; Dai Y; Li N
Anim Biotechnol; 2018 Apr; 29(2):90-99. PubMed ID: 28494220
[TBL] [Abstract][Full Text] [Related]
12. [Animal experiment of recombinant human lactoferrin based on the 28 days repeated oral toxicity].
Ma B; Yuan X; Wang X; Gao P; Zhao Z; Yang J; Peng S; Xu H
Wei Sheng Yan Jiu; 2017 May; 46(3):443-454. PubMed ID: 29903257
[TBL] [Abstract][Full Text] [Related]
13. In vitro effectiveness of recombinant human lactoferrin and its hydrolysate in alleviating LPS-induced inflammatory response.
Aly E; López-Nicolás R; Darwish AA; Ros-Berruezo G; Frontela-Saseta C
Food Res Int; 2019 Apr; 118():101-107. PubMed ID: 30898345
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of a Silk Sericin Hydrogel System Delivering Human Lactoferrin Using Genetically Engineered Silk with Improved Bioavailability to Alleviate Chemotherapy-Induced Immunosuppression.
Xu S; Tan H; Yang Q; Wang R; Tian C; Ji Y; Zhao P; Xia Q; Wang F
ACS Appl Mater Interfaces; 2021 Sep; 13(38):45175-45190. PubMed ID: 34525798
[TBL] [Abstract][Full Text] [Related]
15. Genetically engineered pH-responsive silk sericin nanospheres with efficient therapeutic effect on ulcerative colitis.
Xu S; Yang Q; Wang R; Tian C; Ji Y; Tan H; Zhao P; Kaplan DL; Wang F; Xia Q
Acta Biomater; 2022 May; 144():81-95. PubMed ID: 35288310
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory properties of human recombinant lactoferrin in mice: Implications for therapeutic use in humans.
Artym J; Kocięba M; Zaczyńska E; Adamik B; Kübler A; Zimecki M; Kruzel M
Adv Clin Exp Med; 2018 Mar; 27(3):391-399. PubMed ID: 29533543
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human lactoferrin as a biomaterial for bone tissue engineering: mechanism of antiapoptotic and osteogenic activity.
Amini AA; Nair LS
Adv Healthc Mater; 2014 Jun; 3(6):897-905. PubMed ID: 24352833
[TBL] [Abstract][Full Text] [Related]
18. The dominant expression of functional human lactoferrin in transgenic cloned goats using a hybrid lactoferrin expression construct.
Yu H; Chen J; Sun W; Liu S; Zhang A; Xu X; Wang X; He Z; Liu G; Cheng G
J Biotechnol; 2012 Oct; 161(3):198-205. PubMed ID: 22789477
[TBL] [Abstract][Full Text] [Related]
19. A rice-derived recombinant human lactoferrin stimulates fibroblast proliferation, migration, and sustains cell survival.
Tang L; Cui T; Wu JJ; Liu-Mares W; Huang N; Li J
Wound Repair Regen; 2010; 18(1):123-31. PubMed ID: 20082685
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of recombinant lactoferrin during MRSA infection.
Hwang SA; Kruzel ML; Actor JK
Int Immunopharmacol; 2014 May; 20(1):157-63. PubMed ID: 24613206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
